Patents by Inventor Giorgio Sironi

Giorgio Sironi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel aldosterone antagonists and uses thereof
    Publication number: 20070066580
    Abstract: The present invention relates to novel compounds that are aldosterone receptor antagonists, to pharmaceutical compositions containing the aldosterone receptor antagonists, and to methods of treatment using the same.
    Type: Application
    Filed: September 5, 2006
    Publication date: March 22, 2007
    Applicant: Recordati Ireland Limited
    Inventors: Amedeo Leonardi, Carlo Riva, Paolo Tavecchia, Giorgio Sironi
  • Use of selective antagonists of the ?1B-adrenergic receptor for improvement of sexual dysfunction
    Patent number: 6953800
    Abstract: Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the ?1B-adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: October 11, 2005
    Assignees: Recordati S.A. Chemical, Pharmaceutical Company
    Inventors: Amedeo Leonardi, Gianni Motta, Rodolfo Testa, Giorgio Sironi
  • Lisinopril/lercanidipine combination therapy
    Publication number: 20050101640
    Abstract: Disclosed are compositions and methods for treating hypertension comprising lisinopril and lercanidipine and optionally including a diuretic in amounts effective in combination to reduce blood pressure to a patent in need of treatment.
    Type: Application
    Filed: April 28, 2004
    Publication date: May 12, 2005
    Inventors: Amedeo Leonardi, Abraham Sartani, Giorgio Sironi
  • Lercanidipine/ARB/diuretic therapeutic combinations
    Publication number: 20040198789
    Abstract: Lercanidipine is used in the preparation of a medicament for the treatment of hypertension in combination with the prior, concurrent or post-administration of an angiotensin II receptor blocker (ARB), and optionally, a diuretic. Compositions containing both lercanidipine and the ARB, and optionally, a diuretic are contemplated. Single, once-a-day dosage forms are preferred. A method for the treatment of hypertension in a sub-population of patients with tachycardia is also recited.
    Type: Application
    Filed: March 1, 2004
    Publication date: October 7, 2004
    Applicant: Recordati Ireland Limited
    Inventors: Amedeo Leonardi, Abraham Sartani, Giorgio Sironi
  • Lisinopril/lercanidipine combination therapy
    Publication number: 20040147566
    Abstract: Disclosed are compositions and methods for treating hypertension comprising lisinopril and lercanidipine in amounts effective in combination to reduce blood pressure to a patent in need of treatment.
    Type: Application
    Filed: October 16, 2003
    Publication date: July 29, 2004
    Inventors: Amedeo Leonardi, Abraham Sartani, Giorgio Sironi
  • Combination therapy for hypertension
    Publication number: 20030180355
    Abstract: Disclosed are compositions and methods for treating hypertension comprising enalapril and lercanidipine in amounts effective in combination to reduce blood pressure to a patent in need of treatment.
    Type: Application
    Filed: October 16, 2002
    Publication date: September 25, 2003
    Inventors: Amedeo Leonardi, Abraham Sartani, Giorgio Sironi
  • Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
    Publication number: 20020161009
    Abstract: Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the &agr;1B-adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
    Type: Application
    Filed: August 22, 2001
    Publication date: October 31, 2002
    Applicant: Recordati S.A.
    Inventors: Amedeo Leonardi, Gianni Motta, Rodolfo Testa, Giorgio Sironi
  • Benzopyran derivatives
    Patent number: 6403594
    Abstract: The invention relates to novel benzopyran derivatives of formula I, their N-oxides and pharmaceutically acceptable salts thereof. The compounds are endowed with enhanced selectivity for alpha1-adrenergic receptors and a low activity in lowering blood pressure. The compounds are useful in the treatment of obstructive syndromes of the lower urinary tract, including benign prostatic hyperplasia (BPH), and in the treatment of lower urinary tract symptoms (LUTS), neurogenic lower urinary tract dysfunction (NLUTD), and other conditions.
    Type: Grant
    Filed: October 18, 2000
    Date of Patent: June 11, 2002
    Assignee: Recordati, S.A. Chemical and Pharmaceutical Company
    Inventors: Amedeo Leonardi, Gianni Motta, Carlo Riva, Giorgio Sironi
  • Use of selective antagonists of the &agr;1B-adrenergic receptor for improvement of sexual dysfunction
    Patent number: 6303606
    Abstract: Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the &agr;1B-adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
    Type: Grant
    Filed: May 5, 2000
    Date of Patent: October 16, 2001
    Assignee: Recordati, S.A., Chemical and Pharmaceutical Company
    Inventors: Amedeo Leonardi, Gianni Motta, Rodolfo Testa, Giorgio Sironi